Skip to content

Medical emergency? What to do

Bush picks von Eschenbach as FDA chief

3-RXPublished March 16, 20063 min read

Key points

  • Bush on Wednesday picked physician and cancer survivor Andrew von Eschenbach as head of the Food and Drug Administration.
  • Hillary Rodham Clinton of New York and Patty Murray of Washington announced they plan to put a hold on von Eschenbach's nomination until the FDA makes a decision on a pending request for approval of the Plan B emergency contraceptive.
  • Von Eschenbach, 64, has been acting FDA chief since September.
  • Last summer, Crawford's hearings were stalled by Democratic objections to repeated delays over Barr Pharmaceuticals Inc.'s bid to sell its Plan B emergency contraceptive - which can reduce the chances of pregnancy after unprotected sex if taken within 72 hours - without a prescription.

President George W. Bush on Wednesday picked physician and cancer survivor Andrew von Eschenbach as head of the Food and Drug Administration.

But the nomination of the current acting FDA chief quickly became embroiled in a debate over the long delays in the FDA's decision-making on access to emergency contraception without a prescription.

Democratic Sens. Hillary Rodham Clinton of New York and Patty Murray of Washington announced they plan to put a hold on von Eschenbach's nomination until the FDA makes a decision on a pending request for approval of the Plan B emergency contraceptive.

"It is past time for the FDA to stop dragging its heels and make a decision on Plan B," the senators said in a statement.

Von Eschenbach, 64, has been acting FDA chief since September. He succeeded former FDA commissioner Lester Crawford, who resigned less than three months after surviving a tough Senate battle for confirmation.

Von Eschenbach will face a confirmation hearing before the Senate Health, Education, Labor and Pensions Committee. Both Clinton and Murray are on the Committee.

Last summer, Crawford's hearings were stalled by Democratic objections to repeated delays over Barr Pharmaceuticals Inc.'s bid to sell its Plan B emergency contraceptive - which can reduce the chances of pregnancy after unprotected sex if taken within 72 hours - without a prescription.

Democrats allowed a full Senate vote after they thought the FDA would act on the company's request. But a final decision has still not been made on the proposal, which has lingered at the agency for three years.

DRUG SAFETY CONCERNS

Last week, an aide to Senate health committee chairman Mike Enzi, a Wyoming Republican, said the FDA would need to address the contraceptive issue before the panel acts on a nomination. Enzi issued a statement on Wednesday praising the nomination but did not address the controversy.

In addition to the debate over emergency contraceptives, the FDA also faces recent concerns over drug safety.

Senate Finance Committee Chairman Chuck Grassley, whose panel oversees spending on drugs and other supplies by the federal Medicare and Medicaid health programs, has criticized the FDA's handling of a trial of blood substitutes that tested them on some patients without consent.

He said the agency has "entrenched cultural problems" and likened it to an aircraft carrier in saying it would be hard to turn around.

"It'll take a very determined, reform-minded individual to do it," the Iowa senator said.

When he took the acting FDA job, von Eschenbach stirred controversy by initially keeping his other position as head of the National Cancer Institute. Some consumer advocates viewed that as a conflict of interest and feared his work pushing cancer treatments would cloud his judgment on drug safety.

Von Eschenbach later relinquished his daily duties at the cancer institute.

During the late 1980s, while he was chairman of the urology department at the M.D. Anderson Cancer Center in Houston, a colleague noticed a scalp lesion, which turned out to be melanoma, a dangerous form of skin cancer. But doctors caught it early enough that they were able to treat it. He also has been treated for prostate cancer.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underPublic Health
Public Health

Parasitic DNA proliferates in aging tissues

The genomes of organisms from humans to corn are replete with "parasitic" strands of DNA that, when not suppressed, copy themselves and spread throughout the genome, potentially affecting health. Earlier this year…

4 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.